[1] 国家卫生计生委合理用药专家委员会,中国药师协会. 冠心病合
理用药指南[J].中国医学前沿杂志(电子版),2016,8(6):19-108.
[2] 高润霖. 经皮冠状动脉介入治疗发展历程[J]. 中国医学前沿杂志
(电子版),2015,7(1):1-6.
[3] 陈伟伟,高润霖,刘力生,等.《中国心血管病报告2016》概要[J].
中国循环杂志,2017,32(6):521-530.
[4] 中国冠状动脉血运重建适宜性标准的建议(试行)[J].中国循环杂
志,2016,31(4):313-317.
[5] Rosendorff C, Lackland DT, Allison M, et al. Treatment
of hypertension in patients with coronary artery disease: a
scientific statement from the American Heart Association,
American College of Cardiology, and American Society of
Hypertension [J]. Hypertension, 2015,65(6):1372-1407.
[6] Yang WY, Xiao JZ, Yang ZJ, et al. Serum lipids and lipoproteins
in Chinese men and women [J]. Circulation,
2012(125):2212-2221.
[7] Bartnik M, Rydén L, Ferrari R, et al. The prevalence of
abnormal glucose regulation in patients with coronary artery
disease across Europe. The Euro Heart Survey on diabetes
and the heart [J]. Eur Heart J, 2004,25(21):1880-
1090.
[8] 中国心脏调查组.中国住院冠心病患者糖代谢异常研究-中国心
脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10.
[9] Mongraw- Chaffin ML, Peters SA, Huxley RR, et al.
The sex- specific association between BMI and coronary
heart disease: a systematic review and meta- analysis of 95
cohorts with 1.2 million participants [J]. Lancet Diabetes
Endocrinol, 2015,3(6):437-449.
[10] 刘宝花,王培玉.社会心理因素与冠心病相关研究的进展[J].中华
心血管病杂志,2012,40(4):344-347.